Arax Advisory Partners’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
Other funds holding MIRM
FLSM
JT
Arax Advisory Partners's MIRM Position: Q2 2026 in Review
Arax Advisory Partners opened a new position in Mirum Pharmaceuticals (MIRM) in Q2 2026: 258 shares worth $30.2K. The stake represents ﹤0.01% of the portfolio and ranks #3674 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in MIRM as recently as Q4 2025.
Arax Advisory Partners first reported a position in MIRM in Q3 2025 and has held it in 3 quarters since. The position peaked at $37.5K in Q3 2025. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.
- Arax Advisory Partners held 258 shares of Mirum Pharmaceuticals worth $30.2K as of Q2 2026.
- Mirum Pharmaceuticals was a new Arax Advisory Partners position in Q2 2026.
- Mirum Pharmaceuticals made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3674 holding.
- Arax Advisory Partners first reported a position in Mirum Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
- Arax Advisory Partners's Mirum Pharmaceuticals position peaked at $37.5K in Q3 2025.
- 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.
Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.